Breonics, Inc., a biomedical research firm that joined our supporting member the Harriman Business Center Incubator as a new tenant in January, was awarded a $2.9 million grant from the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) of the National Institutes of Health (NIH). Breonics is developing technology designed to maintain a human organ in a metabolically active state outside the body, and believes the technology holds the potential to more than double the number of cadaveric kidneys available for transplant each year.
This is the second major NIH award received by Breonics in the past year. The new award came from the BRDG-SPAN RC3 Pilot Program funded under the 2009 American Recovery and Reinvestment Act (ARRA), commonly known as the federal economic-stimulus act. The company's previous award came from the National Institute for Immunology, Allergy and Infectious Diseases (NIAID) to develop a technology to protect kidney grafts from rejection.
For more information, please see the news release issued by Empire State Development Corporation (also attached as a pdf), which is the state's economic development agency and the corporate parent of the Harriman Research and Technology Development Corporation. HRTDC is redeveloping the state office complex at the Harriman Campus, as part of a program to position the Capital Region as a technology leader. Building 7A of the Harriman Campus is in use partly as the Harriman Business Center Incubator.